Chemoinformaics analysis of 1,2,2-Trimethyl-2,3-dihydro-indole
| Molecular Weight | 161.248 | nRot | 0 |
| Heavy Atom Molecular Weight | 146.128 | nRig | 15 |
| Exact Molecular Weight | 161.12 | nRing | 2 |
| Solubility: LogS | -3.488 | nHRing | 1 |
| Solubility: LogP | 2.664 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 29.4719 |
| nHD | 0 | BPOL | 16.7581 |
| QED | 0.771 |
| Synth | 2.565 |
| Natural Product Likeliness | 1.497 |
| NR-PPAR-gamma | 0.852 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.262 |
| Pgp-sub | 0.001 |
| HIA | 0.03 |
| CACO-2 | -4.886 |
| MDCK | 0.0000239 |
| BBB | 0.009 |
| PPB | 0.88345 |
| VDSS | 0.858 |
| FU | 0.211426 |
| CYP1A2-inh | 0.94 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.261 |
| CYP2c19-sub | 0.635 |
| CYP2c9-inh | 0.476 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.407 |
| CYP2d6-sub | 0.828 |
| CYP3a4-inh | 0.38 |
| CYP3a4-sub | 0.369 |
| CL | 9.918 |
| T12 | 0.861 |
| hERG | 0.042 |
| Ames | 0.489 |
| ROA | 0.658 |
| SkinSen | 0.679 |
| Carcinogencity | 0.169 |
| EI | 0.825 |
| Respiratory | 0.233 |
| NR-Aromatase | 0.864 |
| Antiviral | No |
| Prediction | 0.771883 |